Factors Associated with Survival of Veterans with Gastrointestinal Neuroendocrine Tumors
Open Access
- 1 January 2012
- journal article
- research article
- Published by Wiley in Journal of Cancer Epidemiology
- Vol. 2012, 1-5
Abstract
Background. Gastrointestinal (GI) neuroendocrine tumor (NET) incidence has been increasing; however, GI NET within the national Veterans Affairs (VA) health system has not been described.Methods. We used the VA Central Cancer Registry to identify the cohort of patients diagnosed with GI NET in 1995–2009. Cox regression models were constructed to explore factors associated with survival.Results. We included 1793 patients with NET of the stomach (9%), duodenum (10%), small intestine (24%), colon (19%) or rectum (38%). Twenty percent were diagnosed in 1995–1999, 35% in 2000–2004, and 45% in 2005–2009. Unadjusted 5-year survival rates were: stomach 56%, duodenum 66%, small intestine 52%, colon 67%, and rectum 84%. Factors associated with shorter survival were increasing age, hazard ratio (HR) 1.05 (95% CI 1.04–1.06), NET location [compared to rectum: stomach HR 2.26 (95% CI 1.68–3.05), duodenum HR 1.70 (95% CI 1.26–2.28), small intestine HR 1.85 (95% CI 1.42–2.42), and colon 1.83 (95% CI 1.41–2.39)], stage [compared toin situ/local: regional HR 1.15 (95% CI 0.90–1.47), distant HR 2.38 (95% CI 1.87–3.05)], and earlier period of diagnosis [compared to 1995–1999: 2000–2004 HR 0.70 (95% CI 0.59–0.85), 2005–2009 HR 0.43 (95% CI 0.34–0.54)].Conclusions. The incidence of GI NET has also increased over time in the VA system with similar survival rates to those observed in non-VA settings. Worsened survival was associated with older age, tumor site, advanced stage, and earlier year of diagnosis.Keywords
Funding Information
- U.S. Department of Veterans Affairs (VA HSRD RCD 03-174, DK38626)
- National Institutes of Health (VA HSRD RCD 03-174, DK38626)
This publication has 12 references indexed in Scilit:
- The Epidemiology of Gastroenteropancreatic Neuroendocrine TumorsEndocrinology and Metabolism Clinics of North America, 2011
- Carcinoid tumors: What should increase our suspicion?Cleveland Clinic Journal of Medicine, 2008
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumoursGut, 2005
- Updated Population-Based Review of Carcinoid TumorsAnnals of Surgery, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Incidence trends and risk factors of carcinoid tumorsCancer, 2001
- An analysis of 8305 cases of carcinoid tumorsCancer, 2000
- Epidemiology of carcinoid tumours in central ItalyEuropean Journal of Epidemiology, 1997
- The epidemiology of carcinoid tumours in England and ScotlandBritish Journal of Cancer, 1994